Osaka Prefectural Hospital Organization Osaka International Cancer Institute

Osaka, Osaka 5418567

1 studies enrolling now · 5 studies all time

What they study most

Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Biliary Tract Cancer, Cervical Cancer, Neoplasms, Progressive Brain Metastasis, Unresectable or Metastatic Melanoma

Studies at this site

• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now
• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer — Running, not enrolling
• Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer — Completed
• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling